IL13RA2 and neoplasm: To test this, we established brain tumor xenografts using ffLuc-expressing PBT030-2, treated the mice intracranially with the IL13Rα2-CAR T cell variants, and then followed tumor size over time using biophotonic imaging (Fig. 5).